Skip to content
Cash Flow Statement · TASI 8300

Wataniya Insurance Co.
Cash and cash equivalents at period end · Insurance operations history.

Cash and cash equivalents at the end of each reporting period. Figures apply to insurance operations. Explore 20 reported observations from 2018 to 2022, with every value linked to its official evidence.

Coverage2018–202220 source-linked periods
Annual history5annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations64.49M SAR
Cash and cash equivalents at period end · Insurance operations0100M200M300M20182019202020212022
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations42.56M SAR
Cash and cash equivalents at period end · Insurance operations0100M200M300M20182019202020212022
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations69.14M SAR
Cash and cash equivalents at period end · Insurance operations0100M200M300M400M20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations50.6M SAR
Cash and cash equivalents at period end · Insurance operations0100M200M300M400M20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
FY 20222022-12-3164,4942022-01-01 to 2022-12-3164.49M SARCash and cash equivalents at end of periodOfficial p. 11 ↗Open statement →
9M / Q3 20222022-09-3050,5982022-01-01 to 2022-09-3050.6M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20222022-06-3069,1422022-01-01 to 2022-06-3069.14M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20222022-03-3142,5572022-01-01 to 2022-03-3142.56M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20212021-12-3133,8642021-01-01 to 2021-12-3133.86M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20212021-09-30113,1082021-01-01 to 2021-09-30113.11M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20212021-06-3054,9422021-01-01 to 2021-06-3054.94M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20212021-03-3161,3342021-01-01 to 2021-03-3161.33M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20202020-12-3166,9302020-01-01 to 2020-12-3166.93M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20202020-09-30304,7552020-01-01 to 2020-09-30304.76M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20202020-06-30365,2152020-01-01 to 2020-06-30365.22M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20202020-03-31266,2272020-01-01 to 2020-03-31266.23M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20192019-12-31292,3542019-01-01 to 2019-12-31292.35M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20192019-09-30262,5212019-01-01 to 2019-09-30262.52M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20192019-06-30280,1462019-01-01 to 2019-06-30280.15M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20192019-03-31252,7422019-01-01 to 2019-03-31252.74M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20182018-12-31259,2332018-01-01 to 2018-12-31259.23M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20182018-09-30251,5082018-01-01 to 2018-09-30251.51M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20182018-06-30229,1622018-01-01 to 2018-06-30229.16M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20182018-03-31244,6472018-01-01 to 2018-03-31244.65M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

الوطنية — Cash and cash equivalents at period end · Insurance operations

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.